Author

Sara Dahan

Observed name: Dahan, Sara

OpenAlex ID: A5111052154

The safety and toxicity profile of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T mutation, supports a Phase 1/2 clinical study

2023 · Lital Friedman, Ofra-Barchad Avitzur, et al. · Expert Opinion on Drug Metabolism & Toxicology · 7

Works count: 2

Citation count: 7

H-index: 1

I10-index: